See all
 |
Articles: Gynecologic Oncology |
Prior Articles
Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix
American Journal of Clinical Oncology, 08/07/09
Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario
Gynecologic Oncology, 08/07/09 Extended left colon resections as part of complete cytoreduction for ovarian cancer: Tips and considerations
Gynecologic Oncology, 08/07/09 Missense Polymorphisms in BRCA1 and BRCA2 and Risk of Breast and Ovarian Cancer
Cancer Epidemiology, Biomarkers & Prevention, 08/07/09 GPR30 predicts poor survival for ovarian cancer
Gynecologic Oncology, 08/06/09 The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: A retrospective cohort study
Gynecologic Oncology, 08/06/09 Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: A phase II study
Gynecologic Oncology, 08/06/09 Total laparoscopic radical hysterectomy for locally advanced cervical carcinoma (stages IIB, IIA and bulky stages IB) after concurrent chemoradiation therapy: Surgical morbidity and oncological results
Gynecologic Oncology, 08/06/09 Anal human papillomavirus infection and abnormal anal cytology in women with genital neoplasia
Gynecologic Oncology, 08/06/09 Comprehensive analysis of human papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma
Gynecologic Oncology, 08/06/09 Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial
Palliative Medicine, 08/06/09 Differences in the risk of cervical cancer and human papillomavirus infection by education level
British Journal of Cancer, 08/06/09 Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells
British Journal of Cancer, 08/06/09 Self-sampling of the vaginal fluid at home combined with high-risk HPV testing
British Journal of Cancer, 08/06/09 Chronic Physical Effects and Health Care Utilization in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study
Journal of Clinical Oncology, 08/06/09 Follow-up for women after treatment for cervical cancer: A systematic review
Gynecologic Oncology, 08/05/09
Revew Article
Rapamycin by itself and additively in combination with carboplatin inhibits the growth of ovarian cancer cells
Gynecologic Oncology, 08/05/09 Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer
Gynecologic Oncology, 08/05/09 Beyond parity: association of ovarian cancer with length of gestation and offspring characteristics
American Journal of Epidemiology, 08/05/09 Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma
Bone Marrow Transplantation, 08/05/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|